No Prescription |
 |
 | ||
|
Spiriva Generic Tiotropium |
|
| ||
No Prescription » Prescription Drugs 15 » Spiriva Generic Tiotropium Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Chemical Name: Tiotropium ( ty-OH-tro-pee-um)Spiriva is a medicine used to treat bronchospasm (wheezing or difficulty in breathing) that is associated with Chronic Obstructive Pulmonary Disease. Spiriva is used to prevent wheezing shortness of breath and difficulty breathing in patients with chronic obstructive pulmonary disease (COPD a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to air sacs in the lungs). Spiriva is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier. Buy Spiriva Generic Tiotropium and other Prescription Drugs 15 products online at Medstore. 3727
About Spiriva Generic Tiotropium: Product Type: Prescription Drugs 15 Spiriva ( Generic Tiotropium ) Spiriva (Generic Tiotropium) Generic Tiotropium 18mcg 30 Capsules Generic Tiotropium Spiriva
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
